New study tracks Octreotide's Real-World impact on acromegaly over two years
NCT ID NCT07583563
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study follows 200 people with acromegaly who are using octreotide subcutaneous depot, a medication that helps control hormone levels. Researchers will monitor safety and effectiveness for up to two years in everyday clinical practice, not a controlled lab setting. The goal is to see how well the drug works in real life and what side effects may occur.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
octreotide subcutaneous depot
What this could lead to
If successful, this study could confirm that octreotide SC depot is a safe and effective long-term treatment option for managing acromegaly in everyday practice.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by patient selection or other factors. It does not test a new drug but gathers real-world data on an existing treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACROMEGALY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fachpraxis für Innere Medizin, Endokrinologie und Diabetologie
NOT_YET_RECRUITINGMagdeburg, 39110, Germany
-
Medicover Neuroendokrinologie MVZ
NOT_YET_RECRUITINGMünchen, 81667, Germany
-
Universitaetsklinikum Aachen
NOT_YET_RECRUITINGAachen, 52074, Germany
-
Universitaetsklinikum Leipzig
RECRUITINGLeipzig, 04103, Germany
-
Universitätsklinikum Würzburg
NOT_YET_RECRUITINGWürzburg, 97080, Germany